Cargando…

Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum

The current Russian and foreign pharmacopoeias either do not provide any information about existing types of viral diseases in horses or do not present it in full. Data of modern domestic and foreign literature was used to prepare the most complete list of viruses that cause equine diseases includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashin, V. V., Sergeev, A. N., Martynova, N. N., Sergeev, A. A., Lys’ko, K. A., Raikov, A. O., Kataeva, V. V., Zagidullin, N. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274627/
https://www.ncbi.nlm.nih.gov/pubmed/35845147
http://dx.doi.org/10.1007/s11094-022-02675-2
_version_ 1784745327002124288
author Mashin, V. V.
Sergeev, A. N.
Martynova, N. N.
Sergeev, A. A.
Lys’ko, K. A.
Raikov, A. O.
Kataeva, V. V.
Zagidullin, N. V.
author_facet Mashin, V. V.
Sergeev, A. N.
Martynova, N. N.
Sergeev, A. A.
Lys’ko, K. A.
Raikov, A. O.
Kataeva, V. V.
Zagidullin, N. V.
author_sort Mashin, V. V.
collection PubMed
description The current Russian and foreign pharmacopoeias either do not provide any information about existing types of viral diseases in horses or do not present it in full. Data of modern domestic and foreign literature was used to prepare the most complete list of viruses that cause equine diseases including 36 infectious agents, 25 of which are pathogenic for humans, 13 of the 25 of which are widespread throughout Russia. Information is provided on the magnitudes of the disease incubation periods (which are most often within one month), the external clinical signs of these diseases (which can also be asymptomatic), and the maximum possible concentrations of viruses in the blood of horses with these diseases (which can reach 8 log conventional units/mL of blood). This information is offered for use in critical production stages of heterologous immunoglobulin drugs for medical use to assure viral safety.
format Online
Article
Text
id pubmed-9274627
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-92746272022-07-12 Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum Mashin, V. V. Sergeev, A. N. Martynova, N. N. Sergeev, A. A. Lys’ko, K. A. Raikov, A. O. Kataeva, V. V. Zagidullin, N. V. Pharm Chem J Article The current Russian and foreign pharmacopoeias either do not provide any information about existing types of viral diseases in horses or do not present it in full. Data of modern domestic and foreign literature was used to prepare the most complete list of viruses that cause equine diseases including 36 infectious agents, 25 of which are pathogenic for humans, 13 of the 25 of which are widespread throughout Russia. Information is provided on the magnitudes of the disease incubation periods (which are most often within one month), the external clinical signs of these diseases (which can also be asymptomatic), and the maximum possible concentrations of viruses in the blood of horses with these diseases (which can reach 8 log conventional units/mL of blood). This information is offered for use in critical production stages of heterologous immunoglobulin drugs for medical use to assure viral safety. Springer US 2022-07-11 2022 /pmc/articles/PMC9274627/ /pubmed/35845147 http://dx.doi.org/10.1007/s11094-022-02675-2 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Mashin, V. V.
Sergeev, A. N.
Martynova, N. N.
Sergeev, A. A.
Lys’ko, K. A.
Raikov, A. O.
Kataeva, V. V.
Zagidullin, N. V.
Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum
title Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum
title_full Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum
title_fullStr Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum
title_full_unstemmed Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum
title_short Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum
title_sort viral safety issues in the production and manufacturing of human immunoglobulin preparations from equine plasma/serum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274627/
https://www.ncbi.nlm.nih.gov/pubmed/35845147
http://dx.doi.org/10.1007/s11094-022-02675-2
work_keys_str_mv AT mashinvv viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT sergeevan viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT martynovann viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT sergeevaa viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT lyskoka viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT raikovao viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT kataevavv viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum
AT zagidullinnv viralsafetyissuesintheproductionandmanufacturingofhumanimmunoglobulinpreparationsfromequineplasmaserum